Email PDF
Image-1Email PDF

Kaufman et al. Avelumab in mMCC Study

Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial.

The physician payment reporting provisions of the Patient Protection and Affordable Care Act of 2010 (the "Sunshine Provisions") require that all applicable manufacturers, including EMD Serono, Inc., track and report to Centers for Medicare & Medicaid Services (CMS) all transfers of value to U.S. physicians, specifically including the value of journal reprints.

Action SVG
Action SVG
Action SVG
eMedI Chat
Close
After your vist, Please answer a few questions to help us improve?
Survey
Please click on icon to provide survey...